Exact Therapeutics (Norway) Price on December 12, 2024
| EXTX Stock | NOK 3.40 0.06 1.73% |
If you're considering investing in Exact Stock, it is important to understand the factors that can impact its price. As of today, the current price of Exact Therapeutics stands at 3.40, as last reported on the 20th of January, with the highest price reaching 3.80 and the lowest price hitting 3.30 during the day. Exact Therapeutics secures Sharpe Ratio (or Efficiency) of -0.11, which denotes the company had a -0.11 % return per unit of standard deviation over the last 3 months. Exact Therapeutics AS exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Exact Therapeutics' Mean Deviation of 2.94, standard deviation of 5.73, and Coefficient Of Variation of (941.93) to check the risk estimate we provide.
Exact Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Exact |
Sharpe Ratio = -0.1113
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EXTX |
Estimated Market Risk
| 6.01 actual daily | 53 53% of assets are less volatile |
Expected Return
| -0.67 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Exact Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Exact Therapeutics by adding Exact Therapeutics to a well-diversified portfolio.
Exact Therapeutics Valuation on December 12, 2024
It is possible to determine the worth of Exact Therapeutics on a given historical date. On December 12, 2024 Exact was worth 3.72 at the beginning of the trading date compared to the closed value of 3.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Exact Therapeutics stock. Still, in general, we apply an absolute valuation method to find Exact Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Exact Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Exact Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.80 | 3.90 | 3.70 | 3.78 | 145,061 | |
12/12/2024 | 3.72 | 4.00 | 3.72 | 3.80 | 87,128 |
| 3.68 | 3.86 | 3.52 | 3.60 | 85,837 |
| Backtest Exact Therapeutics | | | Exact Therapeutics History | | | Exact Therapeutics Valuation | Previous | Next |
Exact Therapeutics Trading Date Momentum on December 12, 2024
| On December 13 2024 Exact Therapeutics AS was traded for 3.60 at the closing time. The highest price during the trading period was 3.86 and the lowest recorded bid was listed for 3.52 . The volume for the day was 85.8 K. This history from December 13, 2024 contributed to the next trading day price decline. The overall trading delta to the next closing price was 5.26% . The overall trading delta to the current price is 10.53% . |
Exact Therapeutics Fundamentals Correlations and Trends
By evaluating Exact Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Exact Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Exact financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Exact Therapeutics Stock history
Exact Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Exact is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Exact Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Exact Therapeutics stock prices may prove useful in developing a viable investing in Exact Therapeutics
EXACT Therapeutics AS, a clinical stage biotech company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy . The company was founded in 2012 and is based in Oslo, Norway. EXACT THERAPEUTICS is traded on Oslo Stock Exchange in Norway.
Exact Therapeutics Stock Technical Analysis
Exact Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Exact Therapeutics Period Price Range
Low | January 20, 2025
| High |
0.00 | 0.00 |
Exact Therapeutics AS cannot be verified against its exchange. Please verify the symbol is currently traded on Oslo Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Exact Therapeutics January 20, 2025 Market Strength
Market strength indicators help investors to evaluate how Exact Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Exact Therapeutics shares will generate the highest return on investment. By undertsting and applying Exact Therapeutics stock market strength indicators, traders can identify Exact Therapeutics AS entry and exit signals to maximize returns
Exact Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Exact Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Exact Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Exact to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.61) | |||
| Total Risk Alpha | (0.75) | |||
| Treynor Ratio | 2.96 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Exact Stock
Exact Therapeutics financial ratios help investors to determine whether Exact Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Exact with respect to the benefits of owning Exact Therapeutics security.